Phase I study of OM-174, a lipid A analogue, with assessment of immunological response, in patients with refractory solid tumors

por Isambert, Nicolas, Fumoleau, Pierre, Paul, Catherine, Ferrand, Christophe, Zanetta, Sylvie, Bauer, Jacques, Ragot, Kevin, Lizard, Gérard, Jeannin, Jean-François, Bardou, Marc
Publicado 2013